Sanders Morris Harris’s Allergan plc AGN Stock Holding History

Sanders Morris Harris’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,500	Closed	-$288K	–	299
2019 Q4	$288K	Hold	1,500	–	–	0.07%	229
2019 Q3	$248K	Hold	1,500	–	–	0.06%	235
2019 Q2	$251K	Buy	+1,500	New	+$208K	0.07%	230
2016 Q2	–	Sell	-2,985	Closed	-$800K	–	338
2016 Q1	$800K	Buy	+2,985	New	+$854K	0.14%	143

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sanders Morris Harris's AGN Position: Q1 2020 in Review

Sanders Morris Harris sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,500 shares — an estimated $288K sold.

Sanders Morris Harris first reported a position in AGN in Q1 2016 and held it in 4 quarters. The position peaked at $800K in Q1 2016. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

Sanders Morris Harris reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
Sanders Morris Harris sold 1,500 Allergan plc shares in Q1 2020, an estimated $288K.
Sanders Morris Harris first reported a position in Allergan plc in Q1 2016 and held it in 4 quarters.
Sanders Morris Harris's Allergan plc position peaked at $800K in Q1 2016.
876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Sanders Morris Harris's 13F filing for Q1 2020, filed 9 Apr 2020.